Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
In the last 90 days, Nuvectis Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Nuvectis Pharma, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +2 vs. Q4 2024
- Shares held
- 2.05M
- +726.4K (+55.0%) vs. Q4 2024
- Total value
- $20.0M
- +$12.9M (+180.6%) vs. Q4 2024
- New holders
- 10
- 13 more added
- Sold out
- 8
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $189.0M |
| Q1 2026 | 62 | $34.9M |
| Q4 2025 | 48 | $32.0M |
| Q3 2025 | 53 | $22.2M |
| Q2 2025 | 47 | $24.2M |
| Q1 2025 | 33 | $20.0M |
| Q4 2024 | 31 | $7.15M |
| Q3 2024 | 31 | $6.60M |
| Q2 2024 | 41 | $7.63M |
| Q1 2024 | 40 | $12.8M |
| Q4 2023 | 36 | $12.6M |
| Q3 2023 | 33 | $16.5M |
| Q2 2023 | 37 | $20.0M |
| Q1 2023 | 13 | $6.34M |
| Q4 2022 | 11 | $7.38M |
| Q3 2022 | 12 | $10.0M |
| Q2 2022 | 11 | $7.20M |
| Q1 2022 | 8 | $4.65M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Nuvectis Pharma, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 467,419 | $4.57M | 0.00% | +142,122+43.7% | Added |
| Baldwin Brothers Inc | 358,461 | $3.50M | 0.25% | +2,500+0.7% | Added |
| Iridian Asset Management LLC | 253,972 | $2.48M | 0.78% | +253,972 | New |
| Geode Capital Management, LLC | 135,333 | $1.32M | 0.00% | +56,090+70.8% | Added |
| Millennium Management LLC | 121,101 | $1.18M | 0.00% | +91,403+307.8% | Added |
| UBS Group AG | 111,520 | $1.09M | 0.00% | +108,851+4,078.3% | Added |
| BlackRock, Inc. | 68,484 | $669.1K | 0.00% | +6,142+9.9% | Added |
| Forbes J M & Co LLP | 59,000 | $576.4K | 0.06% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 45,608 | $445.6K | 0.00% | +45,608 | New |
| Austin Wealth Management, LLC | 40,250 | $441.1K | 0.09% | +40,250 | New |
| Jane Street Group, LLC | 42,299 | $413.3K | 0.00% | +42,299 | New |
| Oppenheimer & Co Inc | 41,000 | $400.6K | 0.01% | +16,000+64.0% | Added |
| Marshall Wace, LLP | 38,874 | $379.8K | 0.00% | −85,697−68.8% | Reduced |
| Northern Trust Corp | 38,058 | $371.8K | 0.00% | +12,333+47.9% | Added |
| Gsa Capital Partners LLP | 34,751 | $340.0K | 0.03% | 00.0% | Unchanged |
| Omers Administration Corp | 32,882 | $321.3K | 0.00% | +32,882 | New |
| State Street Corp | 27,750 | $271.1K | 0.00% | +5,750+26.1% | Added |
| Two Sigma Investments, LP | 20,093 | $196.3K | 0.00% | +1,523+8.2% | Added |
| Edmond de Rothschild Holding S.A. | 15,170 | $148.2K | 0.00% | 00.0% | Unchanged |
| Baxter Bros Inc | 15,000 | $146.6K | 0.02% | 00.0% | Unchanged |
| Nations Financial Group Inc, | 13,500 | $131.9K | 0.01% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 13,483 | $131.7K | 0.00% | +13,483 | New |
| Squarepoint Ops LLC | 11,012 | $107.6K | 0.00% | −8,059−42.3% | Reduced |
| Blue Zone Wealth Advisors, LLC | 10,424 | $101.8K | 0.03% | +10,424 | New |
| Citadel Advisors LLC | 10,344 | $101.1K | 0.00% | +10,344 | New |
| Jain Global LLC | 10,154 | $99.2K | 0.00% | +10,154 | New |
| Morgan Stanley | 6,977 | $68.2K | 0.00% | +4,658+200.9% | Added |
| Bank of America Corp | 1,656 | $16.2K | 0.00% | +41+2.5% | Added |
| Barclays PLC | 1,159 | $11.3K | 0.00% | +15+1.3% | Added |
| Citigroup Inc | 1,025 | $10.0K | 0.00% | +1,025 | New |
| JPMorgan Chase & Co | 179 | $1.75K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 102 | $997 | 0.00% | −13−11.3% | Reduced |
| Steward Partners Investment Advisory, LLC | 100 | $977 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −45,607−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −30,594−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −6,294−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −4,479−100.0% | Sold out |
| Hollencrest Capital Management | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −310−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |